News

Acipimox enhances human skeletal muscle mitochondrial function in clinical study

SBI-797812 turns NAMPT into a “super catalyst” that more efficiently generates NMN

Age-associated mitochondrial DNA point mutations reduce oocyte quality in humans, providing a potential biomarker for embryo viability in assisted reproduction

Nicotinamide mononucleotide (NMN) improved photoreceptor cell survival by increasing cellular health-promoting and antioxidant enzyme levels.

NMN treatment improves blood-brain barrier cell survival and protects against harmful stress in metabolic disorders like diabetes.

Japanese researchers uncover a new role for NAD+ and α-Ketoglutarate in the development of fat

NMN’s restoration of youthful kidney protein levels in aged mice may translate therapeutically to humans.

Welcome to the CPHI in Shanghai！！！

Nicotinamide mononucleotide (NMN) injections inhibit mouse liver cells from driving scarring that leads to liver fibrosis.

Back to back research papers show CD38 enzymes on immune cells driving age-related decline of the critical molecule.

One way that we might sustain healthy levels of NAD+ is by supplementing our bodies with its precursor, nicotinamide mononucleotide (NMN).

The NAD+-consuming enzyme SARM1 is a therapeutic candidate for retinal diseases and vision loss.

A new study indicates age-related inflammation can stimulate CD38 positive immune cell consumption of NAD+.

Researchers show that an enzyme called CD38 on immune cells exhausts levels of an essential molecule for life called NAD+ and its precursor NMN during aging.

Nicotinamide mononucleotide (NMN) intervention protects neurons and memory from diabetes-induced brain degeneration in rats.

Scientists treated old mice with the molecules SS-31 and NMN (nicotinamide mononucleotide) separately to improve different heart functions and when delivered together these molecules acted synergistically to recapitulate the function and metabolism of you

NAD+ metabolism drives tumor escape from the immune response, but boosting NAD+ levels improves the efficacy of anti-cancer therapy.

COVID-19 patients treated with a nicotinamide mononucleotide (NMN) cocktail showed clinical improvements.